Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Hull

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Best Practice & Research. Clinical Gastroenterology|November 30, 2011
Omega-3 polyunsaturated fatty acidsMark A Hull
The Proceedings of the Nutrition Society|February 6, 2020
Nutritional prevention of colorectal cancerMark A Hull
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 16, 2012
Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasiaMark A Hull
European Journal of Cancer (Oxford, England : 1990)|July 9, 2005
Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?Mark A Hull
Cancer Metastasis Reviews|July 5, 2018
Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancerMilene Volpato, Mark A Hull
Nature Reviews. Gastroenterology & Hepatology|March 10, 2011
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancerPrashant Kant, Mark A Hull
Current Opinion in Clinical Nutrition and Metabolic Care|October 12, 2025
Omega-3 polyunsaturated fatty acids and gut microbiotaMark A Hull, Hanyang Sun
Gut|November 8, 2014
Successful delivery of clinical gastroenterology studies in the UKMark A Hull, John T McLaughlin
Cancer Letters|June 3, 2004
Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cellsGillian Hawcroft, Sarah H Gardner, Mark A Hull
World Journal of Gastroenterology|April 8, 2016
Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?Nick E Burr, Mark A Hull, Venkataraman Subramanian
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Best Practice & Research. Clinical Gastroenterology|November 30, 2011
Omega-3 polyunsaturated fatty acidsMark A Hull
The Proceedings of the Nutrition Society|February 6, 2020
Nutritional prevention of colorectal cancerMark A Hull
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 16, 2012
Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasiaMark A Hull
European Journal of Cancer (Oxford, England : 1990)|July 9, 2005
Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?Mark A Hull
Cancer Metastasis Reviews|July 5, 2018
Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancerMilene Volpato, Mark A Hull
Nature Reviews. Gastroenterology & Hepatology|March 10, 2011
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancerPrashant Kant, Mark A Hull
Current Opinion in Clinical Nutrition and Metabolic Care|October 12, 2025
Omega-3 polyunsaturated fatty acids and gut microbiotaMark A Hull, Hanyang Sun
Gut|November 8, 2014
Successful delivery of clinical gastroenterology studies in the UKMark A Hull, John T McLaughlin
Cancer Letters|June 3, 2004
Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cellsGillian Hawcroft, Sarah H Gardner, Mark A Hull
World Journal of Gastroenterology|April 8, 2016
Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?Nick E Burr, Mark A Hull, Venkataraman Subramanian
Pageof 9